Wiegand, Ulrich (2009): Antiangiogenetische Therapie des humanen Pankreaskarzinoms durch ZD6474, ein neuartiger Inhibitor des vaskulären endothelialen Wachstumsfaktorrezeptor VEGF-R2 (KDR/FLK-1) Tyrosinkinase, nach orthotoper Implantation in die Nacktmaus. Dissertation, LMU München: Faculty of Medicine |
Preview |
PDF
Wiegand_Ulrich.pdf 6MB |
DOI: 10.5282/edoc.9892
Item Type: | Theses (Dissertation, LMU Munich) |
---|---|
Subjects: | 600 Technology, Medicine 600 Technology, Medicine > 610 Medical sciences and medicine |
Faculties: | Faculty of Medicine |
Language: | German |
Date of oral examination: | 5. February 2009 |
1. Referee: | Bruns, Christiane |
MD5 Checksum of the PDF-file: | 4ae17dca51dc9e10b57b67639a775fa3 |
Signature of the printed copy: | 0700/UMD 13146 |
ID Code: | 9892 |
Deposited On: | 02. Apr 2009 09:31 |
Last Modified: | 24. Oct 2020 06:19 |
Repository Staff Only: item control page